Skip to content

Park Prescription Trial

Park Prescription Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02615392
Enrollment
160
Registered
2015-11-26
Start date
2016-01-31
Completion date
2017-06-30
Last updated
2017-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

RCT, Park Prescription, Park Use, Physical Activity, Health Promotion, Health Behavior, Mental Well-Being, Body composition, Blood levels, Accelerometry, Improving general physical and mental health

Brief summary

The purpose of this study is to test the effectiveness of prescribing park use (i.e., ''Park Prescription'') to insufficiently active individuals. It is hypothesized that Park Prescription will motivate the target population to increase physical activity and thereby improve their physical and mental health.

Detailed description

BACKGROUND: There are substantial international research findings supporting the role that natural environments play in enhancing human health and the prevention of chronic diseases. Also, there is evidence highlighting the (cost-) effectiveness of prescribing physical activity to promote one's physical activity and health. However, there is a lack of methodologically rigorous studies that have looked into the effectiveness of combining these two promising approaches; i.e., physical activity prescription with a focus on the use of parks and green spaces: Park Prescription. AIMS: This Randomized Controlled Trial (RCT) will investigate the concept of Park Prescription as a health promoting intervention for individuals. The primary objective is to investigate the effectiveness of a park prescription interventions to increase participant's time spent in moderate to vigorous physical activity (MVPA). Main secondary objectives are to assess; A) improvement in physical health (e.g., blood sugar and blood pressure) and health behaviour (e.g., sitting time); B) improvement in mental health (e.g., quality of life); 3) intervention implementation fidelity and the association with park use and perceived study participant satisfaction. METHODOLOGY: Participants aged between 40 and 65 years will be recruited from the Singapore Population Health Community Screening Programme conducted by Alexandra Health Pte Ltd. They will be randomly assigned to one of the following two arms; 1) park prescription + participation in a weekly structured physical activity program conducted in the park, and 2) control group. Participants will be enrolled in the study for a period of 6 months. They will have to complete a baseline assessment, 3-month and 6-month follow-up. The investigators aim to recruit 80 participants in each arm, making a total of 160 study participants.

Interventions

Please refer to the information included in the arm description.

Sponsors

National Parks Board, Singapore
CollaboratorOTHER
Khoo Teck Puat Hospital
CollaboratorOTHER
National University of Singapore
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

Subjects must meet all of the inclusion criteria as listed below to participate in the study. Study participants must: 1. be not currently sufficiently active (less than 150 minutes per week of exercise); 2. complete and pass the PAR-Q+\*; 3. have a blood pressure of less or equal to (\<=) 139 mmHG (systolic) over less or equal to (\<=) 89 mmHG (diastolic); 4. have fasting glucose levels of less or equal to (\<=) 6.0 mmol/l); 5. be Singaporean or Permanent Residents; 6. be able to write and read; 7. provide informed consent.

Exclusion criteria

All subjects meeting any of the following

Design outcomes

Primary

MeasureTime frame
Hours/week spent in Moderate to Vigorous Physical Activity (MVPA) assessed objectively with accelerometryAt 6 months follow-up

Secondary

MeasureTime frame
Total cholesterol (mmol/l)At 6 months follow-up
LDL (mmol/l)At 6 months follow-up
HDL (mmol/l)At 6 months follow-up
Triglycerides (mmol/l)At 6 months follow-up
Blood pressure (mmHG)At 6 months follow-up
Fasting glucose levels (mmol/l)At 6 months follow-up
Waist circumference (cm)At 6 months follow-up
Psychological distress assessed with Kessler-10At 6 months follow-up
Physical and mental health functioning assessed with SF-12At 6 months follow-up
Hours/week spent in Moderate to Vigorous Physical Activity (MVPA) assessed by self-reportAt 6 months follow-up
Hours/week spent in sedentary behaviour assessed by self-reportAt 6 months follow-up
Body Mass Index (kg/m^2)At 6 months follow-up

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026